Skip to content
  • Home
  • World News
  • Business
  • Aviation
195 news

195News

All the news that's fit to print

  • Home
  • World News
  • Business
  • Aviation
  • Toggle search form
  • Vote Yes on Chapter 11 Plan & Recover Your Losses Through FINRA Arbitration
    Vote Yes on Chapter 11 Plan & Recover Your Losses Through FINRA Arbitration Business
  • T.N. Daman Launches Debut Book, Magnetic Message Moves Business
  • In The 2024 Reappraisal, The Harris County Appraisal District Raised Residential Property Values By 2.6% Business
  • USAN Approves Generic Name “Ruxoprubart” for NM8074, an Antibody Therapy focused on Complement-Mediated Diseases Business
  • Toiletries Market Size, Share And Growth Analysis For 2024-2033 World News
  • VHF Air-Ground Communication Stations Market Set to Reach $2.2 Billion by 2031, With a Sustainable CAGR Of 7.2% Aviation
  • “Hand in Hand, Building a Better Community” 2025 International Women’s Day Forum Successfully Held Business
  • Percepio AB Announces Collaboration Accelerating Automotive Software Observability Aviation

ZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine

Posted on October 10, 2022 By NewsEditor
ZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic MedicineZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic MedicineThe wearable sustained acoustic medicine (sam®) treatment has been effectively utilized by sports medicine doctors, athletes and beyond to help rapidly treat tendon, ligament and other soft-tissue injuries.

ZetrOZ Systems’ sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine

TRUMBULL, Conn. - October 10, 2022 - (Newswire.com)

ZetrOZ Systems, creator and manufacturer of the sam® wearable ultrasound device product line, is continuing to expand its clinical education program on the benefits of sustained acoustic medicine for soft tissue healing, the usage of the pain relief treatment and attaining health insurance coverage of the pain relief device. 

Sustained Acoustic Medicine (sam®) is the only home-use bioregenerative medical device cleared by the U.S. Food & Drug Administration for the treatment of select medical indications, most commonly for chronic joint pain of the shoulder, knee and elbow, and the treatment of overuse injuries. More than 50 clinical and scientific studies support its effectiveness in healing injuries, restoring function and returning patients to work and everyday activities.

"Our sam® technology is touching thousands of lives daily, and we want to continue providing education to more healthcare providers as a way to bring this innovative intervention forward to Americans who can benefit from this treatment," said Dr. George Lewis, founder and CEO of ZetrOZ Systems. "This technology offers results without the need for opioids or other drugs while treating and healing patients up to 40% faster than standard methodologies."

Clinical education on sam® is directed by Dr. Rod Walters and Dr. Rajiv Mallipudi. Walters is a nationally recognized leader in athletic training with decades of experience at major universities and as a consultant to clients including the National Football League, the Big 12 Athletic Conference and Cirque du Soleil. He was inducted into the National Athletic Trainers Association Hall of Fame in 2005.

Dr. Mallipudi, MD, M.H.S, is a board-certified internal medicine hospitalist physician and assistant clinical professor at the Yale School of Medicine in New Haven, Conn. He is an active clinical researcher on healthcare quality improvement, with projects examining methods to reduce length of stay for hospital patients and to improve patient outcomes.

Walters and Mallipudi have a shared goal of educating physicians, physical therapists and athletic trainers about the benefits and use of the sam® device, in hopes of reducing the need for surgeries and pain medication and improving patients' likelihood of returning to work, sports and normal daily activities. By providing clinical training resources, including online videos, medical professionals now have information on best practices for the drug-free and non-invasive treatment of patients' injuries.

Adherence to a sam® regimen across the repair phase provides a necessary and safe intervention to ensure patients avoid chronic, recurring injuries. Recommended practices are specified in the education materials and include:

  • The sam® treatment can be applied with one or two ultrasound stimulators.
  • The sam® device should be applied a minimum of four times a week.
  • Treatments should be applied incrementally to assess patients' response to treatment, from an initial one-hour treatment to a maximum of four hours per treatment.
  • For acute conditions, treatment duration can range from 4 to 8 weeks.
  • For chronic conditions, treatment can range from 2 to 12 weeks.

Clinical education instructs physicians that sam® can serve as a stand-alone treatment or be used to supplement other treatment approaches to stimulate soft-tissue repair and that its value is as a treatment option that does not require surgery or pain relief medications. 

The sam® treatment also is a cost-effective treatment option. For example, a 2020 study on knee osteoarthritis, published in the Journal of Orthopaedic Surgery and Research, found sam® provided a greater improvement in functional effectiveness per dollar of care than the standard care options. 

ZetrOZ Systems continues to provide education on sam® technology, most recently participating in the annual PHATS (Professional Hockey Athletic Trainers Society) SPHEM (Society of Professional Hockey Equipment Managers) 2022 Conference in June. Findings showed sam® is a non-invasive, non-narcotic alternative to pain, and that the device's ease of use led athletes to return to normal activity after treatment.

To learn more, visit zetrozsystems.com.

About ZetrOZ Systems
ZetrOZ Systems is leading healing innovation in sports medicine, developing wearable bioelectronic devices for the delivery of sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on proprietary medical technology of +46 patents and is the exclusive manufacturer and developer of sam®, a product line designed for the treatment of acute and chronic musculoskeletal conditions. To learn more, visit zetrozsystems.com.


Contact Information:
Buse Kayar
[email protected]


Press Release Service by Newswire.com

Original Source: ZetrOZ Systems' sam® Ultrasound Technology Expands Clinical Education on Sustained Acoustic Medicine
Business

Post navigation

Previous Post: Kolaboration Ventures Expands Product Lineup Through Mission Nurseries Acquisition
Next Post: laWow Publishes Lawsuits in Wall Street Legal Battle Between Wallentine, Engaged Capital Over Fraud Allegations

Related Posts

  • Food Preservatives Market Crosses $3,671.7 Million by 2031 with a Masterstroke CAGR of 3.4% Business
  • Juan Carlos Samaniego Achieves Amazon Best-Seller Status with “Never Give Up,” Co-Authored with Dick Vitale Business
  • University of Virginia- Darden School of Business, Boston University, University of Regina Release Research: News From Artificial Intelligence is Believed Less Business
  • Summit Group Solutions, LLC Names New Senior Director of Operations Business
  • Loanspark Partners with Tax Titans to Empower SMBs with Pioneering Financial and Tax Services Business
  • Local Security Selects Penticton for Network Operations Center Business
November 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
« Oct    
last celebrity gossip
Gossip Stone - celebrity life and gossip

Recent Posts

  • The Assisted Reproductive Technology Market is to grow at a CAGR of 8.9%, reaching a value of $56.96 billion by 2030.November 16, 2026
  • Atopic Dermatitis Market Expected to Grow Steadily at a 14.6% CAGR Until 2030November 15, 2026
  • Forecast Report on the Semiconductor Chip Design Market Including Segment Analysis and Strategic Industry InsightsNovember 14, 2026
  • The Assisted Living Technologies Market is projected to grow to $17.76 billion by 2030, expanding at a CAGR of 13.8%November 14, 2026
  • Artificio Launches AI Agents That Work the SAP MRP Exception List Before Planners Start Their DayNovember 13, 2026
Brand Values Content
VUGA Enterprises - media network PR & Marketing
  • Questions raised over safety of planned Rosatom nuclear power plants in Uzbekistan. Business
  • LTV Ukraine War Chronicles. Day 722 pt1: Who Are Russians?  – Latynina.tv – Alexey Arestovych
    LTV Ukraine War Chronicles. Day 722 pt1: Who Are Russians? – Latynina.tv – Alexey Arestovych World News
  • Agricultural Tractors Market Size Worth USD 97.8 Billion by 2031 With CAGR of 5.6% Business
  • Opterro, Inc. and NeST Technology Enabled Services Partner to Bring Advanced Fiber-Optic Sensing Solutions to India Aviation
  • Cheval Wellness to Host Free PCOS/PMOS Screening and Fertility Event Ahead of Condition’s Historic Name Change World News
  • Low-Cost Carrier Market Projected Expansion to $595.1+ Billion Market Value by 2032; with a 12.1% CAGR During 2023-2032 Aviation
  • TOOTRiS Child Care Benefits Help Semiconductor Manufacturers Access CHIPS Act Federal Funds Business
  • CSNK2A1 Foundation Funds Innovative Research in the Chow Lab to Expedite Potential Treatments for OCNDS World News
aerospace company
stem cell clinic in kiev
medical spa in miami
Fashion TV free

Copyright © 2026 195 News. All Rights Reserved by Coolaser

Powered by .